2-溴-2-(2-氟苯基)乙酸乙酯 | 100638-28-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-溴-2-(2-氟苯基)乙酸乙酯
• 中文别名: 乙基2-溴-2-(2-氟苯基)乙酸甲酯
• 英文名称: ethyl α-bromo-o-fluorophenylacetate
• 英文别名: ethyl α-bromoorthofluorophenylacetate；Ethyl 2-bromo-2-(2-fluorophenyl)acetate
• CAS: 100638-28-6
• 化学式: C₁₀H₁₀BrFO₂
• 分子量: 261.091
• InChiKey: YKRLHAOXUXKBRE-UHFFFAOYSA-N

物化性质

• 沸点：
  265.5±25.0 °C(Predicted)
• 密度：
  1.476±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-溴-2-(2-氟苯基)乙酸乙酯 在 sodium hydroxide 作用下， 生成 2-(4-Boc-哌嗪)-2-(2-氟苯基)乙酸
  参考文献：
  名称：

  Privileged structure based ligands for melanocortin receptors—Substituted benzylic piperazine derivatives

  摘要：

  Replacement of the aryl piperazine moiety in compound I with a variety of substituted benzylic piperazines (6) yields compounds that afford melanocortin receptor 4 (MCR4) activity. Analogs with ortho substitution on the aromatic ring afforded the highest affinity. Resolution of the stereocenter of the benzylic piperazine based privileged structure revealed that the R-enantiomer was more active. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.08.018
• 作为产物：
  描述：

  2-氟苯基乙酸乙酯 在 N-溴代丁二酰亚胺(NBS) 作用下， 生成 2-溴-2-(2-氟苯基)乙酸乙酯
  参考文献：
  名称：

  Privileged structure based ligands for melanocortin receptors—Substituted benzylic piperazine derivatives

  摘要：

  Replacement of the aryl piperazine moiety in compound I with a variety of substituted benzylic piperazines (6) yields compounds that afford melanocortin receptor 4 (MCR4) activity. Analogs with ortho substitution on the aromatic ring afforded the highest affinity. Resolution of the stereocenter of the benzylic piperazine based privileged structure revealed that the R-enantiomer was more active. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.08.018

文献信息

• Heterocyclic aldose reductase inhibitors and methods of using them
  申请人：Carbipem

  公开号：US04755509A1

  公开（公告）日：1988-07-05

  The invention relates to new compounds of the formula: ##STR1## Aldose reductase inhibitors. Treatment of certain complications of diabetes.

  这项发明涉及新化合物，其公式为：##STR1## 醛糖还原酶抑制剂。治疗糖尿病的某些并发症。
• Pd-Catalyzed Divergent C(sp²)–H Activation/Cycloimidoylation of 2-Isocyano-2,3-diarylpropanoates
  作者：Shi Tang、Sheng-Wen Yang、Hongwei Sun、Yali Zhou、Juan Li、Qiang Zhu

  DOI：10.1021/acs.orglett.8b00346

  日期：2018.4.6

  A Pd-catalyzed site-selective C(sp(2))-H activation/cycloimidoylation of 2-isocyano-2,3-diarylpropanoates to construct diverse cyclic imine products has been developed. Six-membered 3,4-dihydroisoquinolines containing a C3 quaternary carbon center were generated dominantly by using bulky Ad(2)Pn-Bu as a ligand, while five-membered 1,1-disubstituted 1H-isoindoles were formed preferentially in the presence of bidentate phosphine ligand DPPB. The selectivity for 1H-isoindole formation was enhanced by using steric hindered aryl iodides. DFT calculations suggested that the experimentally observed ligand-controlled selectivity was a result of trans effect.
• A Comparative Molecular Field Analysis Model for 6-Arylpyrrolo[2,1-d][1,5]benzothiazepines Binding Selectively to the Mitochondrial Benzodiazepine Receptor
  作者：Giovanni Greco、Ettore Novellino、Isabella Fiorini、Vito Nacci、Giuseppe Campiani、Silvia M. Ciani、Antonio Garofalo、Paola Bernasconi、Tiziana Mennini

  DOI：10.1021/jm00050a007

  日期：1994.11

  A series of 42 6-arylpyrrolo[2,1-d][1,5]benzothiazepines which we have recently described as selective ligands of the mitochondrial benzodiazepine receptor (MBR) (Fiorini I.; et al. J. Med. Chem. 1994, 37, 1427-1438), have been investigated using the comparative molecular field analysis (CoMFA) approach. The resulting 3D-QSAR model rationalizes the steric and electronic factors which modulate affinity to the MBR with a cross-validation standard error of 0.648 pIC(50) unit. A set of seven novel pyrrolobenzothiazepine congeners has successively been synthesized and tested. The CoMFA model forecasts the binding affinity values of these new compounds with a prediction standard error of 0.536.
• US4755509A
  申请人：——

  公开号：US4755509A

  公开（公告）日：1988-07-05